Holen Sie sich die Stockscreener-App
7.40
5.71%
0.40
Handel nachbörslich:
7.45
0.05
+0.68%
Finanzdaten der Phathom Pharmaceuticals Inc-Aktie (PHAT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
27.40%
74.27
|
58.30 | 57.58 | 49.50 | 39.50 |
| Cost Of Revenue |
25.84%
15.10
|
12.00 | 7.648 | 6.19 | 5.038 |
| Gross Profit |
27.80%
59.18
|
46.30 | 49.94 | 43.31 | 34.47 |
Operating Expenses
|
2.20%
63.14
|
61.78 | 55.86 | 58.59 | 94.39 |
| Operating Income/Loss |
74.38%
-3.965
|
-15.48 | -5.928 | -15.27 | -59.92 |
| Nonoperating Income/Loss |
8.56%
-13.62
|
-14.89 | -15.22 | -14.70 | -15.89 |
| Net Income/Loss |
42.11%
-17.58
|
-30.37 | -21.15 | -29.97 | -75.81 |
| Basic Average Shares |
2.07%
83.75
|
82.05 | 0.3029 | 73.40 | 72.47 |
| Diluted Average Shares |
2.07%
83.75
|
82.05 | 0.3029 | 73.40 | 72.47 |
| Basic Earnings Per Share |
43.24%
-0.21
|
-0.37 | -0.27 | -0.41 | -1.05 |
| Diluted Earnings Per Share |
43.24%
-0.21
|
-0.37 | -0.27 | -0.41 | -1.05 |
3.13%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):